Hannah Berntsson

BSc MSc

School of Medicine and Population Health

Study Manager/Quality Assurance Manager

h.berntsson@sheffield.ac.uk
+44 114 222 8278

Barber House

Full contact details

Hannah Berntsson
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ

Profile

I joined the Clinical Trials Research Unit in January 2020 as a Research Assistant working on the ASTIClite Trial, which is a CTIMP investigating the efficacy of autologous haematopoietic stem cell transplantation for Crohn’s disease.

Prior to joining the CTRU I worked for Sheffield Teaching Hospitals department of Neuroscience as a research administrator, supporting trials across a range of conditions within neurology. I have a BSc in Psychology from City University London and an MSc in Translational Neuroscience from the University of Sheffield.

Qualifications

BSc Psychology

MSc Translational Neuroscience

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Bamford E, Berntsson H, Beale S, Desoysa L, Dias J, Hamer-Kiwacz S, Hind D, Johnson N, Loban A, Molloy K , Morvan E et al (2024) Flexor Injury Rehabilitation Splint Trial (FIRST): protocol for a pragmatic randomised controlled trial comparing three splints for finger flexor tendon repairs. Trials, 25(1). View this article in WRRO
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Din S , Emsley R et al (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11(3). View this article in WRRO
Berntsson H, Thien A, Hind D, Stewart L, Mahzabin M, Tung WS, Bradburn M & Kurien M (2024) Interventions for managing late gastrointestinal symptoms following pelvic radiotherapy: a systematic review and meta-analysis. Clinical Oncology, 36(5), 318-334. View this article in WRRO
Lindsay JO, Hind D, Swaby E, Berntsson H, Bradburn M, Bannur U, Byrne J, Clarke C, Desoysa L, Dickins B , Din S et al (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. View this article in WRRO
Bursnall M, Thomas BD, Berntsson H, Strong E, Brayne M & Hind D (2022) Clinician and patient experience of internet-mediated eye movement desensitisation and reprocessing therapy. Journal of Psychosocial Rehabilitation and Mental Health, 9(3), 251-262. View this article in WRRO
Boxell EG, Malik Y, Wong J, Lee MH, Berntsson HM, Lee MJ, Bourne RS, McCullagh IJ, Hind D & Wilson MJ (2021) Are treatment effects consistent with hypothesized mechanisms of action proposed for postoperative delirium interventions? Reanalysis of systematic reviews. Journal of Comparative Effectiveness Research, 10(17), 1301-1315. View this article in WRRO

Preprints

Bamford E, Berntsson H, Beale S, Desoysa L, Dias J, Hamer-Kiwacz S, Hind D, Johnson N, Loban A, Molloy K , Morvan E et al (2024) Flexor Injury Rehabilitation Splint Trial (FIRST): Protocol for a pragmatic randomised controlled trial comparing three splints for finger flexor tendon repairs, Springer Science and Business Media LLC.
Scott AJ, Flowers O, Sheldon E, Berntsson H & Rowse G (2021) Perceptions of sleep in Inflammatory Bowel Disease and the acceptability of sleep interventions in routine care: A qualitative study, Center for Open Science.